|
Q1 FY2027
As of Aug 31, 2026
|
Q4 FY2026
As of May 31, 2026
|
Q3 FY2026
As of Feb 28, 2026
|
Q2 FY2026
As of Nov 30, 2025
|
Q1 FY2026
As of Aug 31, 2025
|
Q4 FY2025
As of May 31, 2025
|
Q3 FY2025
As of Feb 28, 2025
|
Q2 FY2025
As of Nov 30, 2024
|
Q1 FY2025
As of Aug 31, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Oct 31, 2021
|
Q1 FY2022
As of Jul 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSET | ||||||||||||||||||||
| Current asset | ||||||||||||||||||||
| Prepayments | ||||||||||||||||||||
| Total current asset | ||||||||||||||||||||
| TOTAL ASSET | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Other payables and accrued liabilities | ||||||||||||||||||||
| Due to parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current liabilities | ||||||||||||||||||||
| Due to parties | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| Common stocks, $0.001 par value, 500,000,000 shares authorized, 3,441,000 as of August 31, 2026 and May 31, 2026, respectively. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||||||||||||||||||||
Loading...
